• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Enfusion Inc. (Amendment)

    1/19/24 4:15:04 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email
    SC 13G/A 1 ea191849-13ga1malh_enfu.htm AMENDMENT NO. 1 TO SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

     

    UNDER THE SECURITIES AND EXCHANGE ACT OF 1934

    (Amendment No. 1)*

     

     

    Enfusion, Inc.

    (Name of Issuer)

     

    Class A common stock

    (Title of Class of Securities)

     

    292812104

    (CUSIP Number)

     

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    x Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No. 292812104

    1

    NAME OF REPORTING PERSONS

     

    Malherbe Investments LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨       (b)  ¨ 

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY  
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    9,870,386 (1) 

    6

    SHARED VOTING POWER

     

    0 

    7

    SOLE DISPOSITIVE POWER

     

    9,870,386 (1) 

    8

    SHARED DISPOSITIVE POWER

     

    0 

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    9,870,386 (1) 

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ¨

      

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    10.06% (2) 

    12

    TYPE OF REPORTING PERSON

     

    OO 

     

    (1)Represents 9,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.
    (2)This percentage is based on 98,149,996 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) the 9,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.

     

    2

     

     

    1

    NAME OF REPORTING PERSONS

      

    Stephen Malherbe

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a)   ¨       (b)  ¨

    3

    SEC USE ONLY

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States of America  

    NUMBER OF
    SHARES
    BENEFICIALLY  
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5

    SOLE VOTING POWER

     

    9,870,386 (1) 

    6

    SHARED VOTING POWER

     

    0 

    7

    SOLE DISPOSITIVE POWER

     

    9,870,386 (1) 

    8

    SHARED DISPOSITIVE POWER

     

    0 

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    9,870,386 (1) 

    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ☐

     

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    10.06% (2) 

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Represents 9,870,386 shares of Class A common stock that  Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.
    (2)This percentage is based on 98,149,996 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) the 9,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.

     

    3

     

     

    Item 1

     

    (a)Name of Issuer:

     

    Enfusion, Inc.

     

    (b)Address of Issuer’s Principal Executive Offices:
       

    125 South Clark Street, Suite 750, Chicago, Illinois 60603

    Item 2

     

    (a)Name of Person Filing:

     

    This statement is filed by Malherbe Investments LLC and Stephen Malherbe (together, the “Reporting Persons”). Mr. Malherbe is the sole manager of Malherbe Investments LLC and may be deemed the beneficial owner of the shares held by Malherbe Investments LLC.

     

    (b)Address of Principal Business Office or, if None, Residence:

     

    The principal business office address of the Reporting Persons is 1063 Gallant Court, Wheaton, Illinois 60187.

     

    (c)Citizenship:

     

    Malherbe Investments LLC is a Delaware limited liability company and Stephen Malherbe is a citizen of the United States of America.

     

    (d)Title of Class of Securities:

     

    Class A common stock, par value $0.001 per share  

     

    (e)CUSIP Number:

     

    292812104

     

    Item 3If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
           
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
           
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
           
      (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
           
      (k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    4

     

     

    Item 4Ownership.

     

    I.         Malherbe Investments LLC

     

    (a) Amount beneficially owned: 9,870,386 (1)
    (b) Percent of class: 10.06% (2)

    (c) Number of shares as to which such person has:

      (i) Sole power to vote or direct the vote: 9,870,386 (1)
    (ii)Shared power to vote or direct the vote: 0
    (iii)Sole power to dispose or direct the disposition: 9,870,386 (1)
    (iv)Shared power to dispose or direct the disposition: 0

     

    II.         Stephen Malherbe

     

    (a) Amount beneficially owned: 9,870,386 (1)

    (b) Percent of class: 10.06% (2)

    (c) Number of shares as to which such person has:

    (i)Sole power to vote or direct the vote: 9,870,386 (1)
    (ii)Shared power to vote or direct the vote: 0
    (iii)Sole power to dispose or direct the disposition: 9,870,386 (1)
    (iv)Shared power to dispose or direct the disposition: 0

     

    (1)Represents 9,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

     

    (2)This percentage is based on 98,149,996 shares of Class A Common Stock outstanding, which is the sum of (i) 88,279,610 shares of Class A Common Stock outstanding as of November 5, 2023, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on November 7, 2023, and (ii) the 9,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act..

     

    Item 5Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10Certification.

     

    Not applicable.

     

    5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: January 19, 2024

     

      Malherbe Investments LLC
       
      By: /s/ Stephen Malherbe
        Name:   Stephen Malherbe
        Title: Sole Manager

     

      By: /s/ Stephen Malherbe
        Stephen Malherbe

     

    6

     

     

    EXHIBIT INDEX

     

    Exhibit No.  

    Description

    99.1   Joint Filing Agreement, dated as of February 16, 2022 (incorporated by reference to exhibit 99.1 of the Schedule 13G filed by the Reporting Persons on February 16, 2022).

     

     

    7

     

    Get the next $ENFN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Enfusion with a new price target

      Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

      5/10/24 8:40:24 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by Goldman with a new price target

      Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

      2/28/24 6:16:11 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by JP Morgan with a new price target

      JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

      1/30/24 6:55:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OPENLANE Names Brad Herring Chief Financial Officer

      Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

      4/22/25 4:15:00 PM ET
      $ENFN
      $FOUR
      $KAR
      Computer Software: Prepackaged Software
      Technology
      Business Services
      Consumer Discretionary
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

      Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

      4/17/25 8:00:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Financials

    Live finance-specific insights

    See more
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion Announces Fourth Quarter and Full Year 2024 Results

      Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $36.9 million with an Adjusted Gross Profit Margin of 69.6%. Net Income was $0.2 million with a Net Income Margin of 0.3%. Adjusted EBITDA was $12.3 million, up 25.3% compared to the same period in the prior year. Operating Cash Fl

      3/3/25 4:05:00 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

      Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features multimedia. View the full release here: https

      1/13/25 6:30:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Leadership Updates

    Live Leadership Updates

    See more
    • FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

      FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

      10/29/24 7:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

      Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

      10/10/24 9:00:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

      Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

      9/23/24 8:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services

    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/29/24 7:13:25 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/25/24 4:30:55 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      9/6/24 3:32:03 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form EFFECT filed by Enfusion Inc.

      EFFECT - Enfusion, Inc. (0001868912) (Filer)

      4/24/25 12:15:09 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form POS AM filed by Enfusion Inc.

      POS AM - Enfusion, Inc. (0001868912) (Filer)

      4/21/25 4:57:41 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:12 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:09 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/21/25 5:11:16 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology